Portage, MI, United States of America

Dale L Kling

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt, Ludwig-Maximilians-Universitat München. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dale L Kling. Retrieved from https://idiyas.com/inventor/dale-l-kling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dale L. Kling

Introduction

Dale L. Kling is a notable inventor based in Portage, MI (US). She has made significant contributions to the field of pharmacology, particularly with her work on the (S)-enantiomer of mepazine. Her innovative approach has led to advancements in therapeutic applications.

Latest Patents

Dale L. Kling holds a patent for the (S)-enantiomer of mepazine. The present invention relates to the (S)-enantiomer of mepazine, its applicability in therapy, a pharmacological composition comprising (S)-mepazine, and processes for the preparation of (S)-mepazine and one of its intermediates. This patent highlights her expertise in developing effective pharmaceutical solutions.

Career Highlights

Throughout her career, Dale L. Kling has worked with prestigious institutions such as Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt and Ludwig-Maximilians-Universität München. Her experience in these organizations has contributed to her knowledge and skills in the field of research and development.

Collaborations

Dale L. Kling has collaborated with notable colleagues, including Daniel Krappmann and Daniel Nagel. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Dale L. Kling's contributions to the field of pharmacology through her patent on the (S)-enantiomer of mepazine demonstrate her commitment to advancing therapeutic applications. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…